What’s preventing pharma teams from scaling content excellence?
Jindrich Borovsky and Maurice van Leeuwen on fragmented ownership of the content supply chain, why reuse keeps being built as a software feature, and why AI belongs at the end of the sequence. Full recording, chapters and transcript.
Watch the recording

